Published online before print September 25, 2003, doi: 10.1161/01.ATV.0000095973.42032.44
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
© 2003 American Heart Association, Inc.
Atherosclerosis and Lipoproteins |
Circle of Willis Atherosclerosis Is a Risk Factor for Sporadic Alzheimer’s Disease
From the Longtine Center for Molecular Biology and Genetics (A.E.R., C.E., W.K., D.C.L.), Sun Health Research Institute, Sun City; Department of Microbiology (T.A.K.), School of Osteopathic Medicine, Midwestern University, Glendale; and Department of Epidemiology and Biostatistics (J.D.S.) and W. H. Civin Laboratory for Neuropathology (L.I.S.), Sun Health Research Institute, Sun City, Ariz.
Correspondence to Alex E. Roher, Longtine Center for Molecular Biology and Genetics, Sun Health Research Institute, 10515 W Santa Fe Dr, Sun City, AZ 85351. E-mail alex.roher{at}sunhealth.org
Objectives— We conducted a quantitative investigation of brain arterial atherosclerotic damage and its relationship to sporadic Alzheimer’s disease (AD).
Methods and Results— Fifty-four consecutive autopsy cases, 32 AD and 22 nondemented control subjects, were examined to establish the degree of arterial stenosis. Vessel external and lumenal area measurements were taken from 3-mm arterial cross-sections to calculate a stenosis index. AD patient circle of Willis arteries possessed a significant degree of stenosis as a consequence of multiple and severe atherosclerotic lesions. These lesions were significantly more severe in AD cases than in age-matched controls (P<0.0001), and the number of stenoses and the index of occlusion (R=0.67; P<0.00001) were positively correlated. In addition, the index of stenosis significantly correlated with the following measures of AD neuropathological lesions: total plaque score, neuritic plaque score, neurofibrillary tangle score, Braak stage score, and white matter rarefaction score.
Conclusions— Our study reveals an association between severe circle of Willis atherosclerosis and sporadic AD that should be considered a risk factor for this dementia. These observations strongly suggest that atherosclerosis-induced brain hypoperfusion contributes to the clinical and pathological manifestations of AD.
Key Words: atherosclerosis • circle of Willis • Alzheimer’s disease • brain hypoperfusion
This article has been cited by other articles:
 |
|
 |
|
  X.-K. Tong and E. Hamel Transforming Growth Factor-beta1 Impairs Endothelin-1-Mediated Contraction of Brain Vessels by Inducing Mitogen-Activated Protein (MAP) Kinase Phosphatase-1 and Inhibiting p38 MAP Kinase Mol. Pharmacol., December 1, 2007; 72(6): 1476 - 1483. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. H. Kuller Green Banana*: Dementia Epidemiology Research: It Is Time to Modify the Focus of Research J. Gerontol. A Biol. Sci. Med. Sci., December 1, 2006; 61(12): 1314 - 1318. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. Thanvi and T. Robinson Sporadic cerebral amyloid angiopathy--an important cause of cerebral haemorrhage in older people Age Ageing, November 1, 2006; 35(6): 565 - 571. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. S. Beeri, M. Rapp, J. M. Silverman, J. Schmeidler, H. T. Grossman, J. T. Fallon, D. P. Purohit, D. P. Perl, A. Siddiqui, G. Lesser, et al. Coronary artery disease is associated with Alzheimer disease neuropathology in APOE4 carriers Neurology, May 9, 2006; 66(9): 1399 - 1404. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Silvestrini, P. Pasqualetti, R. Baruffaldi, M. Bartolini, Y. Handouk, M. Matteis, F. Moffa, L. Provinciali, and F. Vernieri Cerebrovascular Reactivity and Cognitive Decline in Patients With Alzheimer Disease Stroke, April 1, 2006; 37(4): 1010 - 1015. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. M. Erlich, K. L. Lunetta, L. A. Cupples, M. Huyck, R. C. Green, C. T. Baldwin, L. A. Farrer, and for the MIRAGE Study Group Polymorphisms in the PON gene cluster are associated with Alzheimer disease Hum. Mol. Genet., January 1, 2006; 15(1): 77 - 85. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 X.-K. Tong, N. Nicolakakis, A. Kocharyan, and E. Hamel Vascular Remodeling versus Amyloid {beta}-Induced Oxidative Stress in the Cerebrovascular Dysfunctions Associated with Alzheimer's Disease J. Neurosci., November 30, 2005; 25(48): 11165 - 11174. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. A. Velliquette, T. O'Connor, and R. Vassar Energy Inhibition Elevates {beta}-Secretase Levels and Activity and Is Potentially Amyloidogenic in APP Transgenic Mice: Possible Early Events in Alzheimer's Disease Pathogenesis J. Neurosci., November 23, 2005; 25(47): 10874 - 10883. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. E. Roher, C. Esh, T. Kokjohn, L. Sue, T. Beach, L. S. Honig, W. Kukull, and R. Mayeux Atherosclerosis and AD: Analysis of data from the US National Alzheimer's Coordinating Center Neurology, September 27, 2005; 65(6): 974 - 974. [Full Text] [PDF]
|
|
|
|
|
|
L. H. Kuller, O. L. Lopez, W. J. Jagust, J. T. Becker, S. T. DeKosky, C. Lyketsos, C. Kawas, J.C.S. Breitner, A. Fitzpatrick, and C. Dulberg Determinants of vascular dementia in the Cardiovascular Health Cognition Study Neurology, May 10, 2005; 64(9): 1548 - 1552. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Park, J. Anrather, P. Zhou, K. Frys, R. Pitstick, S. Younkin, G. A. Carlson, and C. Iadecola NADPH Oxidase-Derived Reactive Oxygen Species Mediate the Cerebrovascular Dysfunction Induced by the Amyloid {beta} Peptide J. Neurosci., February 16, 2005; 25(7): 1769 - 1777. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. E. Roher, C. Esh, A. Rahman, T. A. Kokjohn, and T. G. Beach Atherosclerosis of Cerebral Arteries in Alzheimer Disease Stroke, November 1, 2004; 35(11_suppl_1): 2623 - 2627. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Iadecola Atherosclerosis and Neurodegeneration: Unexpected Conspirators in Alzheimer's Dementia Arterioscler. Thromb. Vasc. Biol., November 1, 2003; 23(11): 1951 - 1953. [Full Text] [PDF]
|
|